JERUSALEM -- (MARKET WIRE) -- 10/19/07 -- IDenta Corp. (PINKSHEETS: IDTA) has added to the present line of drug detectors -- (Marijuana, Cocaine/Crack, Heroin, Methamphetamine/Amphetamine, Ecstasy (MDMA) / MDA, GHB, LSD) -- more improved and highly specific field testing kits for:

1. Ketamine -- powder or in liquid form

2. Flunitazepam (in solid state)

3. Ephedrine (-- with known chemistry).

The new drug detector kits are on the same high level as the kits currently being used, in the chemical aspect and are very user friendly devices.

The new kits will be presented at a news conference during the November business trip (by the CEO and the Chief Scientist) in the USA and Canada, at the meetings with officials and at the CNOA conference. (RENO - NEVADA, November 16-18, 2007)

Due to the changes that have happened in the industry of field drug detectors in the last few months (the main supplier of the field drug detectors has suspended supplying kits for the International market), IDenta Corp. has made a strategical decision to develop and to manufacture in the near future, drug detectors for all the rest of the present illicit drugs (Methaqualone, Morphine, Pentazocine and Propoxyphene) with improved and highly selective field testing kits. Because of this action, IDenta is expecting increased orders throughout the international market.

The three new detectors listed above and the future drug detectors will make it much easier for IDenta to supply the demands of the legal law enforcement agencies around the world, and to solidify the company's position as the world leader in the forensics industry.

Therefore, any company or agency will be able to purchase all their drug and explosive detectors through one company (IDenta Corp.) and will receive the most accurate detectors on the market.

To the best of the company's knowledge, IDenta Corp. is the only company on the market with a scientific R&D capability in the field of street drug detection.

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning
IDenta's products internationally contact:
Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
fpi@drugsdetector.com

For Investor Relations in the US contact:
Randy Jacobs
Corporate Spokesman
IDentaNews@sitcomllc.com
1-800-316-9437

For information about the Accutest - IDenta products in the US please
contact:
Mr. Eyal Golan
COO
JANT PHARMACAL CORPORATION
16255 Ventura Blvd. #505
Encino, CA 91436
Toll Free: 800-676-5565
www.accutest.net